Lanean...
MEK inhibitors: a new class of chemotherapeutic agents with ocular toxicity
A new class of chemotherapeutic agents, MEK inhibitors, has recently been developed and is proving to be an effective treatment for a number of cancers. A pattern of ocular adverse events has followed these drugs through clinical trials and their association with retinopathy is only just beginning t...
Gorde:
| Argitaratua izan da: | Eye (Lond) |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Publishing Group
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4541356/ https://ncbi.nlm.nih.gov/pubmed/26043707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2015.82 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|